Long-term outcome after parathyroidectomy for lithium-induced hyperparathyroidism

Background The accepted management of lithium‐associated hyperparathyroidism (LiHPT) is open four‐gland parathyroid exploration (OPTX). This approach has recently been the subject of controversy. A recent study has shown very high long‐term recurrence rates after OPTX, whereas some have promoted uni...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of surgery Jg. 101; H. 10; S. 1252 - 1256
Hauptverfasser: Norlén, O., Sidhu, S., Sywak, M., Delbridge, L.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Chichester, UK John Wiley & Sons, Ltd 01.09.2014
Oxford University Press
Schlagworte:
ISSN:0007-1323, 1365-2168, 1365-2168
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Background The accepted management of lithium‐associated hyperparathyroidism (LiHPT) is open four‐gland parathyroid exploration (OPTX). This approach has recently been the subject of controversy. A recent study has shown very high long‐term recurrence rates after OPTX, whereas some have promoted unilateral focused parathyroidectomy as appropriate management. The aim was to evaluate long‐term outcomes after surgery for LiHPT and to assess the accuracy of preoperative imaging. Methods This was a retrospective cohort study that comprised all patients undergoing initial surgery for LiHPT between 1990 and 2013. The cumulative recurrence rate was calculated by the Kaplan–Meier method. The sensitivity and specificity of sestamibi scintigraphy and ultrasound imaging for identification of single‐gland versus multigland disease was investigated using intraoperative assessment as reference. Results Of 48 patients, 45 had OPTX and three underwent focused parathyroidectomy. Multiglandular disease was documented in 27 patients and 21 had a single adenoma. The median follow‐up was 5·9 (range 0·3–22) years and 16 patients died during follow‐up. The 10‐year cumulative recurrence rate was 16 (95 per cent confidence interval 2 to 29) per cent. No permanent complications occurred after primary surgery for LiHPT. Twenty‐four patients had at least one preoperative ultrasound or sestamibi scan. For concordant sestamibi scintigraphy and ultrasound imaging, the sensitivity and specificity for identifying single‐gland versus multigland disease was five of nine and five of eight respectively. Conclusion Surgery provided a safe and effective management option for patients with LiHPT in this series, with a long‐term cure rate of well over 80 per cent. Surgery is an option
AbstractList The accepted management of lithium-associated hyperparathyroidism (LiHPT) is open four-gland parathyroid exploration (OPTX). This approach has recently been the subject of controversy. A recent study has shown very high long-term recurrence rates after OPTX, whereas some have promoted unilateral focused parathyroidectomy as appropriate management. The aim was to evaluate long-term outcomes after surgery for LiHPT and to assess the accuracy of preoperative imaging.BACKGROUNDThe accepted management of lithium-associated hyperparathyroidism (LiHPT) is open four-gland parathyroid exploration (OPTX). This approach has recently been the subject of controversy. A recent study has shown very high long-term recurrence rates after OPTX, whereas some have promoted unilateral focused parathyroidectomy as appropriate management. The aim was to evaluate long-term outcomes after surgery for LiHPT and to assess the accuracy of preoperative imaging.This was a retrospective cohort study that comprised all patients undergoing initial surgery for LiHPT between 1990 and 2013. The cumulative recurrence rate was calculated by the Kaplan-Meier method. The sensitivity and specificity of sestamibi scintigraphy and ultrasound imaging for identification of single-gland versus multigland disease was investigated using intraoperative assessment as reference.METHODSThis was a retrospective cohort study that comprised all patients undergoing initial surgery for LiHPT between 1990 and 2013. The cumulative recurrence rate was calculated by the Kaplan-Meier method. The sensitivity and specificity of sestamibi scintigraphy and ultrasound imaging for identification of single-gland versus multigland disease was investigated using intraoperative assessment as reference.Of 48 patients, 45 had OPTX and three underwent focused parathyroidectomy. Multiglandular disease was documented in 27 patients and 21 had a single adenoma. The median follow-up was 5·9 (range 0·3-22) years and 16 patients died during follow-up. The 10-year cumulative recurrence rate was 16 (95 per cent confidence interval 2 to 29) per cent. No permanent complications occurred after primary surgery for LiHPT. Twenty-four patients had at least one preoperative ultrasound or sestamibi scan. For concordant sestamibi scintigraphy and ultrasound imaging, the sensitivity and specificity for identifying single-gland versus multigland disease was five of nine and five of eight respectively.RESULTSOf 48 patients, 45 had OPTX and three underwent focused parathyroidectomy. Multiglandular disease was documented in 27 patients and 21 had a single adenoma. The median follow-up was 5·9 (range 0·3-22) years and 16 patients died during follow-up. The 10-year cumulative recurrence rate was 16 (95 per cent confidence interval 2 to 29) per cent. No permanent complications occurred after primary surgery for LiHPT. Twenty-four patients had at least one preoperative ultrasound or sestamibi scan. For concordant sestamibi scintigraphy and ultrasound imaging, the sensitivity and specificity for identifying single-gland versus multigland disease was five of nine and five of eight respectively.Surgery provided a safe and effective management option for patients with LiHPT in this series, with a long-term cure rate of well over 80 per cent.CONCLUSIONSurgery provided a safe and effective management option for patients with LiHPT in this series, with a long-term cure rate of well over 80 per cent.
Background: The accepted management of lithium-associated hyperparathyroidism (LiHPT) is open four-gland parathyroid exploration (OPTX). This approach has recently been the subject of controversy. A recent study has shown very high long-term recurrence rates after OPTX, whereas some have promoted unilateral focused parathyroidectomy as appropriate management. The aim was to evaluate long-term outcomes after surgery for LiHPT and to assess the accuracy of preoperative imaging. Methods: This was a retrospective cohort study that comprised all patients undergoing initial surgery for LiHPT between 1990 and 2013. The cumulative recurrence rate was calculated by the Kaplan-Meier method. The sensitivity and specificity of sestamibi scintigraphy and ultrasound imaging for identification of single-gland versus multigland disease was investigated using intraoperative assessment as reference. Results: Of 48 patients, 45 had OPTX and three underwent focused parathyroidectomy. Multiglandular disease was documented in 27 patients and 21 had a single adenoma. The median follow-up was 5.9 (range 0.3-22) years and 16 patients died during follow-up. The 10-year cumulative recurrence rate was 16 (95 per cent confidence interval 2 to 29) per cent. No permanent complications occurred after primary surgery for LiHPT. Twenty-four patients had at least one preoperative ultrasound or sestamibi scan. For concordant sestamibi scintigraphy and ultrasound imaging, the sensitivity and specificity for identifying single-gland versus multigland disease was five of nine and five of eight respectively. Conclusion: Surgery provided a safe and effective management option for patients with LiHPT in this series, with a long-term cure rate of well over 80 per cent.
Background The accepted management of lithium-associated hyperparathyroidism (LiHPT) is open four-gland parathyroid exploration (OPTX). This approach has recently been the subject of controversy. A recent study has shown very high long-term recurrence rates after OPTX, whereas some have promoted unilateral focused parathyroidectomy as appropriate management. The aim was to evaluate long-term outcomes after surgery for LiHPT and to assess the accuracy of preoperative imaging. Methods This was a retrospective cohort study that comprised all patients undergoing initial surgery for LiHPT between 1990 and 2013. The cumulative recurrence rate was calculated by the Kaplan-Meier method. The sensitivity and specificity of sestamibi scintigraphy and ultrasound imaging for identification of single-gland versus multigland disease was investigated using intraoperative assessment as reference. Results Of 48 patients, 45 had OPTX and three underwent focused parathyroidectomy. Multiglandular disease was documented in 27 patients and 21 had a single adenoma. The median follow-up was 5·9 (range 0·3-22) years and 16 patients died during follow-up. The 10-year cumulative recurrence rate was 16 (95 per cent confidence interval 2 to 29) per cent. No permanent complications occurred after primary surgery for LiHPT. Twenty-four patients had at least one preoperative ultrasound or sestamibi scan. For concordant sestamibi scintigraphy and ultrasound imaging, the sensitivity and specificity for identifying single-gland versus multigland disease was five of nine and five of eight respectively. Conclusion Surgery provided a safe and effective management option for patients with LiHPT in this series, with a long-term cure rate of well over 80 per cent. Surgery is an option [PUBLICATION ABSTRACT]
The accepted management of lithium-associated hyperparathyroidism (LiHPT) is open four-gland parathyroid exploration (OPTX). This approach has recently been the subject of controversy. A recent study has shown very high long-term recurrence rates after OPTX, whereas some have promoted unilateral focused parathyroidectomy as appropriate management. The aim was to evaluate long-term outcomes after surgery for LiHPT and to assess the accuracy of preoperative imaging. This was a retrospective cohort study that comprised all patients undergoing initial surgery for LiHPT between 1990 and 2013. The cumulative recurrence rate was calculated by the Kaplan-Meier method. The sensitivity and specificity of sestamibi scintigraphy and ultrasound imaging for identification of single-gland versus multigland disease was investigated using intraoperative assessment as reference. Of 48 patients, 45 had OPTX and three underwent focused parathyroidectomy. Multiglandular disease was documented in 27 patients and 21 had a single adenoma. The median follow-up was 5·9 (range 0·3-22) years and 16 patients died during follow-up. The 10-year cumulative recurrence rate was 16 (95 per cent confidence interval 2 to 29) per cent. No permanent complications occurred after primary surgery for LiHPT. Twenty-four patients had at least one preoperative ultrasound or sestamibi scan. For concordant sestamibi scintigraphy and ultrasound imaging, the sensitivity and specificity for identifying single-gland versus multigland disease was five of nine and five of eight respectively. Surgery provided a safe and effective management option for patients with LiHPT in this series, with a long-term cure rate of well over 80 per cent.
Background The accepted management of lithium‐associated hyperparathyroidism (LiHPT) is open four‐gland parathyroid exploration (OPTX). This approach has recently been the subject of controversy. A recent study has shown very high long‐term recurrence rates after OPTX, whereas some have promoted unilateral focused parathyroidectomy as appropriate management. The aim was to evaluate long‐term outcomes after surgery for LiHPT and to assess the accuracy of preoperative imaging. Methods This was a retrospective cohort study that comprised all patients undergoing initial surgery for LiHPT between 1990 and 2013. The cumulative recurrence rate was calculated by the Kaplan–Meier method. The sensitivity and specificity of sestamibi scintigraphy and ultrasound imaging for identification of single‐gland versus multigland disease was investigated using intraoperative assessment as reference. Results Of 48 patients, 45 had OPTX and three underwent focused parathyroidectomy. Multiglandular disease was documented in 27 patients and 21 had a single adenoma. The median follow‐up was 5·9 (range 0·3–22) years and 16 patients died during follow‐up. The 10‐year cumulative recurrence rate was 16 (95 per cent confidence interval 2 to 29) per cent. No permanent complications occurred after primary surgery for LiHPT. Twenty‐four patients had at least one preoperative ultrasound or sestamibi scan. For concordant sestamibi scintigraphy and ultrasound imaging, the sensitivity and specificity for identifying single‐gland versus multigland disease was five of nine and five of eight respectively. Conclusion Surgery provided a safe and effective management option for patients with LiHPT in this series, with a long‐term cure rate of well over 80 per cent. Surgery is an option
Author Sywak, M.
Norlén, O.
Sidhu, S.
Delbridge, L.
Author_xml – sequence: 1
  givenname: O.
  surname: Norlén
  fullname: Norlén, O.
  email: olov.norlen@me.com
  organization: University of Sydney Endocrine Surgery Unit, Sydney, New South Wales, Australia
– sequence: 2
  givenname: S.
  surname: Sidhu
  fullname: Sidhu, S.
  organization: University of Sydney Endocrine Surgery Unit, Sydney, New South Wales, Australia
– sequence: 3
  givenname: M.
  surname: Sywak
  fullname: Sywak, M.
  organization: University of Sydney Endocrine Surgery Unit, Sydney, New South Wales, Australia
– sequence: 4
  givenname: L.
  surname: Delbridge
  fullname: Delbridge, L.
  organization: University of Sydney Endocrine Surgery Unit, Sydney, New South Wales, Australia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25043401$$D View this record in MEDLINE/PubMed
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-231983$$DView record from Swedish Publication Index (Uppsala universitet)
BookMark eNpd0cFu1DAQBmALFdFtQeIJUCQuHJriycSOc2wX2oIiEKLA0XLWTtdLEgc7Vpu3J9GWBXEaWf7kX57_hBz1rjeEvAR6DpRmb-tdOC-ZKJ-QFSBnaQZcHJEVpbRIATM8Jich7CgFpCx7Ro4zRnPMKazIl8r1d-lofJe4OG5cZxLVzMdkUF6N28k7q81mdN2UNM4nrR23Nnap7XXcGJ1sp8H4f6gN3XPytFFtMC8e5yn5dvX-dn2TVp-vP6wvqtSiYGXaCMrrRqgm13VWm4KCyGuWKY112XDBec0xz3NeKooN6EZwxTQUoCFXJeeAp-Rs_264N0Os5eBtp_wknbLynf1-IZ2_kzHKDKEUOPM3ez549yuaMMrOho1pW9UbF4MExhAonwNn-vo_unPR9_NnFpVhgTks-a8eVaw7ow_5f3Y7g3QP7m1rpsM9ULl0JufO5NKZvPz4dZl_vQ2jeTh45X9KXmDB5I9P17K6Bbyqihu5xt92UJlz
CODEN BJSUAM
ContentType Journal Article
Copyright 2014 BJS Society Ltd. Published by John Wiley & Sons Ltd
2014 BJS Society Ltd. Published by John Wiley & Sons Ltd.
Copyright © 2014 BJS Society Ltd. Published by John Wiley & Sons, Ltd.
Copyright_xml – notice: 2014 BJS Society Ltd. Published by John Wiley & Sons Ltd
– notice: 2014 BJS Society Ltd. Published by John Wiley & Sons Ltd.
– notice: Copyright © 2014 BJS Society Ltd. Published by John Wiley & Sons, Ltd.
DBID BSCLL
CGR
CUY
CVF
ECM
EIF
NPM
K9.
7X8
ADTPV
AOWAS
DF2
DOI 10.1002/bjs.9589
DatabaseName Istex
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
SwePub
SwePub Articles
SWEPUB Uppsala universitet
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

ProQuest Health & Medical Complete (Alumni)
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
EISSN 1365-2168
EndPage 1256
ExternalDocumentID oai_DiVA_org_uu_231983
3398162051
25043401
BJS9589
ark_67375_WNG_LT13FL7H_C
Genre article
Evaluation Studies
Journal Article
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OC
1ZS
23N
31~
36B
3O-
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5RE
5VS
5WD
66C
6J9
6P2
702
7PT
8-0
8-1
8-3
8-4
8-5
8F7
8UM
930
A01
A03
AABZA
AACZT
AAESR
AAEVG
AAGQS
AAMMB
AANHP
AAONW
AAPGJ
AAPXW
AAQQT
AARHZ
AAUAY
AAVAP
AAWDT
AAYEP
AAZKR
ABCQN
ABCUV
ABDFA
ABEJV
ABEML
ABGNP
ABIJN
ABJNI
ABLJU
ABNHQ
ABOCM
ABPQP
ABPTD
ABPVW
ABQNK
ABVGC
ABWST
ABXVV
ACBWZ
ACFBH
ACFRR
ACGFO
ACGFS
ACMXC
ACPOU
ACRPL
ACSCC
ACUTJ
ACVCV
ACXQS
ACYHN
ACYXJ
ACZBC
ADBBV
ADEOM
ADIPN
ADIYS
ADIZJ
ADKYN
ADMGS
ADMTO
ADNBA
ADNMO
ADQBN
ADVEK
ADXAS
ADZMN
AEFGJ
AEGXH
AEIMD
AEMQT
AENEX
AFBPY
AFFNX
AFFQV
AFFZL
AFGKR
AFXAL
AFYAG
AFYLJ
AFZJQ
AGMDO
AGQPQ
AGQXC
AGUTN
AGXDD
AHGBF
AHMBA
AHMMS
AI.
AIAGR
AIDQK
AIDYY
AIURR
AJAOE
AJBYB
AJDVS
AJEEA
AJNCP
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALXQX
AMBMR
AMYDB
APJGH
AQDSO
ASPBG
ATGXG
ATUGU
AVNTJ
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BCRHZ
BDRZF
BEYMZ
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBS
EJD
EMOBN
EX3
F00
F01
F04
F5P
FEDTE
FLUFQ
FOEOM
FUBAC
G-S
G.N
GNP
GODZA
H.X
H13
HBH
HF~
HHY
HHZ
HVGLF
HZ~
IH2
IHE
IX1
J0M
J5H
JPC
JXSIZ
KBUDW
KOP
KQQ
KSI
KSN
L7B
LAW
LC2
LC3
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M65
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N4W
N9A
NF~
NNB
NOMLY
NU-
O66
O9-
OAUYM
OBFPC
OCZFY
OHH
OIG
OJZSN
OPAEJ
OVD
OWPYF
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
ROX
RX1
RYL
SUPJJ
TEORI
TMA
UB1
V2E
V8K
V9Y
VH1
VVN
W8V
W99
WBKPD
WH7
WHWMO
WIB
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WVDHM
WXI
X7M
XG1
XV2
YFH
YOC
YUY
ZGI
ZXP
ZY1
ZZTAW
~IA
~WT
1OB
33P
AAHHS
ACCFJ
ADZOD
AEEZP
AEQDE
AEUQT
AFPWT
AIWBW
AJBDE
ESX
LATKE
RGB
RIG
RWI
WRC
WUP
CGR
CUY
CVF
ECM
EIF
NPM
K9.
O8X
7X8
ADTPV
AOWAS
DF2
ID FETCH-LOGICAL-i3859-f806bf8af4db2be70184b52ad3b9f6866b6344469a03f1df86a5d171d14a96613
IEDL.DBID DRFUL
ISICitedReferencesCount 15
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000340606800009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0007-1323
1365-2168
IngestDate Tue Nov 04 17:27:34 EST 2025
Sat Sep 27 20:00:20 EDT 2025
Sat Nov 29 15:07:24 EST 2025
Thu Apr 03 07:10:49 EDT 2025
Wed Jan 22 16:58:50 EST 2025
Tue Nov 11 03:31:49 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
License 2014 BJS Society Ltd. Published by John Wiley & Sons Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-i3859-f806bf8af4db2be70184b52ad3b9f6866b6344469a03f1df86a5d171d14a96613
Notes ArticleID:BJS9589
istex:C753369704F45B8E021709BD4491961E6C9D1B74
ark:/67375/WNG-LT13FL7H-C
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
PMID 25043401
PQID 1552373411
PQPubID 976337
PageCount 5
ParticipantIDs swepub_primary_oai_DiVA_org_uu_231983
proquest_miscellaneous_1553106469
proquest_journals_1552373411
pubmed_primary_25043401
wiley_primary_10_1002_bjs_9589_BJS9589
istex_primary_ark_67375_WNG_LT13FL7H_C
PublicationCentury 2000
PublicationDate September 2014
PublicationDateYYYYMMDD 2014-09-01
PublicationDate_xml – month: 09
  year: 2014
  text: September 2014
PublicationDecade 2010
PublicationPlace Chichester, UK
PublicationPlace_xml – name: Chichester, UK
– name: England
– name: Oxford
PublicationTitle British journal of surgery
PublicationTitleAlternate Br J Surg
PublicationYear 2014
Publisher John Wiley & Sons, Ltd
Oxford University Press
Publisher_xml – name: John Wiley & Sons, Ltd
– name: Oxford University Press
References Marti JL, Yang CS, Carling T, Roman SA, Sosa JA, Donovan P et al. Surgical approach and outcomes in patients with lithium-associated hyperparathyroidism. Ann Surg Oncol 2012; 19: 3465-3471.
Szalat A, Mazeh H, Freund HR. Lithium-associated hyperparathyroidism: report of four cases and review of the literature. Eur J Endocrinol 2009; 160: 317-323.
Bendz H, Schon S, Attman PO, Aurell M. Renal failure occurs in chronic lithium treatment but is uncommon. Kidney Int 2010; 77: 219-224.
Mallette LE, Khouri K, Zengotita H, Hollis BW, Malini S. Lithium treatment increases intact and midregion parathyroid hormone and parathyroid volume. J Clin Endocrinol Metab 1989; 68: 654-660.
McHenry CR, Racke F, Meister M, Warnaka P, Sarasua M, Nemeth EF et al. Lithium effects on dispersed bovine parathyroid cells grown in tissue culture. Surgery 1991; 110: 1061-1066.
Melkersson K, Dahl ML. Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications. Drugs 2004; 64: 701-723.
Kandil E, Dackiw AP, Alabbas H, Abdullah O, Tufaro AP, Tufano RP. A profile of patients with hyperparathyroidism undergoing lithium therapy for affective psychiatric disorders. Head Neck 2011; 33: 925-927.
Bendz H, Sjodin I, Toss G, Berglund K. Hyperparathyroidism and long-term lithium therapy - a cross-sectional study and the effect of lithium withdrawal. J Int Med 1996; 240: 357-365.
Norman J, Lopez J, Politz D. Abandoning unilateral parathyroidectomy: why we reversed our position after 15 000 parathyroid operations. J Am Coll Surg 2012; 214: 260-269.
Livingstone C, Rampes H. Lithium: a review of its metabolic adverse effects. J Psychopharmacol 2006; 20: 347-355.
Sloand JA, Shelly MA. Normalization of lithium-induced hypercalcemia and hyperparathyroidism with cinacalcet hydrochloride. Am J Kidney Dis 2006; 48: 832-837.
Wolf ME, Moffat M, Mosnaim J, Dempsey S. Lithium therapy, hypercalcemia, and hyperparathyroidism. Am J Ther 1997; 4: 323-325.
Järhult J, Ander S, Asking B, Jansson S, Meehan A, Kristoffersson A et al. Long-term results of surgery for lithium-associated hyperparathyroidism. Br J Surg 2010; 97: 1680-1685.
Ananth J, Dubin SE. Lithium and symptomatic hyperparathyroidism. J R Soc Med 1983; 76: 1026-1029.
Lehmann SW, Lee J. Lithium-associated hypercalcemia and hyperparathyroidism in the elderly: what do we know? J Affect Disord 2013; 146: 151-157.
Rizwan MM, Perrier ND. Long-term lithium therapy leading to hyperparathyroidism: a case report. Perspect Psychiatr Care 2009; 45: 62-65.
Geoffroy PA, Bellivier F, Henry C. [Treatment of manic phases of bipolar disorder: critical synthesis of international guidelines.] Encephale 2014; [Epub ahead of print].
Awad SS, Miskulin J, Thompson N. Parathyroid adenomas versus four-gland hyperplasia as the cause of primary hyperparathyroidism in patients with prolonged lithium therapy. World J Surg 2003; 27: 486-488.
Schneider DF, Mazeh H, Sippel RS, Chen H. Is minimally invasive parathyroidectomy associated with greater recurrence compared to bilateral exploration? Analysis of more than 1000 cases. Surgery 2012; 152: 1008-1015.
Abdullah H, Bliss R, Guinea AI, Delbridge L. Pathology and outcome of surgical treatment for lithium-associated hyperparathyroidism. Br J Surg 1999; 86: 91-93.
Carchman E, Ogilvie J, Holst J, Yim J, Carty S. Appropriate surgical treatment of lithium-associated hyperparathyroidism. World J Surg 2008; 32: 2195-2199.
2009; 45
1991; 110
2010; 77
2012; 152
2004; 64
2010; 97
2006; 20
2009; 160
2006; 48
1983; 76
2011; 33
2013; 146
2003; 27
2012; 19
2008; 32
1999; 86
2014
1996; 240
2012; 214
1989; 68
1997; 4
References_xml – reference: Livingstone C, Rampes H. Lithium: a review of its metabolic adverse effects. J Psychopharmacol 2006; 20: 347-355.
– reference: Kandil E, Dackiw AP, Alabbas H, Abdullah O, Tufaro AP, Tufano RP. A profile of patients with hyperparathyroidism undergoing lithium therapy for affective psychiatric disorders. Head Neck 2011; 33: 925-927.
– reference: Marti JL, Yang CS, Carling T, Roman SA, Sosa JA, Donovan P et al. Surgical approach and outcomes in patients with lithium-associated hyperparathyroidism. Ann Surg Oncol 2012; 19: 3465-3471.
– reference: Melkersson K, Dahl ML. Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications. Drugs 2004; 64: 701-723.
– reference: Norman J, Lopez J, Politz D. Abandoning unilateral parathyroidectomy: why we reversed our position after 15 000 parathyroid operations. J Am Coll Surg 2012; 214: 260-269.
– reference: Mallette LE, Khouri K, Zengotita H, Hollis BW, Malini S. Lithium treatment increases intact and midregion parathyroid hormone and parathyroid volume. J Clin Endocrinol Metab 1989; 68: 654-660.
– reference: Szalat A, Mazeh H, Freund HR. Lithium-associated hyperparathyroidism: report of four cases and review of the literature. Eur J Endocrinol 2009; 160: 317-323.
– reference: McHenry CR, Racke F, Meister M, Warnaka P, Sarasua M, Nemeth EF et al. Lithium effects on dispersed bovine parathyroid cells grown in tissue culture. Surgery 1991; 110: 1061-1066.
– reference: Geoffroy PA, Bellivier F, Henry C. [Treatment of manic phases of bipolar disorder: critical synthesis of international guidelines.] Encephale 2014; [Epub ahead of print].
– reference: Awad SS, Miskulin J, Thompson N. Parathyroid adenomas versus four-gland hyperplasia as the cause of primary hyperparathyroidism in patients with prolonged lithium therapy. World J Surg 2003; 27: 486-488.
– reference: Sloand JA, Shelly MA. Normalization of lithium-induced hypercalcemia and hyperparathyroidism with cinacalcet hydrochloride. Am J Kidney Dis 2006; 48: 832-837.
– reference: Lehmann SW, Lee J. Lithium-associated hypercalcemia and hyperparathyroidism in the elderly: what do we know? J Affect Disord 2013; 146: 151-157.
– reference: Järhult J, Ander S, Asking B, Jansson S, Meehan A, Kristoffersson A et al. Long-term results of surgery for lithium-associated hyperparathyroidism. Br J Surg 2010; 97: 1680-1685.
– reference: Wolf ME, Moffat M, Mosnaim J, Dempsey S. Lithium therapy, hypercalcemia, and hyperparathyroidism. Am J Ther 1997; 4: 323-325.
– reference: Ananth J, Dubin SE. Lithium and symptomatic hyperparathyroidism. J R Soc Med 1983; 76: 1026-1029.
– reference: Rizwan MM, Perrier ND. Long-term lithium therapy leading to hyperparathyroidism: a case report. Perspect Psychiatr Care 2009; 45: 62-65.
– reference: Schneider DF, Mazeh H, Sippel RS, Chen H. Is minimally invasive parathyroidectomy associated with greater recurrence compared to bilateral exploration? Analysis of more than 1000 cases. Surgery 2012; 152: 1008-1015.
– reference: Abdullah H, Bliss R, Guinea AI, Delbridge L. Pathology and outcome of surgical treatment for lithium-associated hyperparathyroidism. Br J Surg 1999; 86: 91-93.
– reference: Bendz H, Schon S, Attman PO, Aurell M. Renal failure occurs in chronic lithium treatment but is uncommon. Kidney Int 2010; 77: 219-224.
– reference: Bendz H, Sjodin I, Toss G, Berglund K. Hyperparathyroidism and long-term lithium therapy - a cross-sectional study and the effect of lithium withdrawal. J Int Med 1996; 240: 357-365.
– reference: Carchman E, Ogilvie J, Holst J, Yim J, Carty S. Appropriate surgical treatment of lithium-associated hyperparathyroidism. World J Surg 2008; 32: 2195-2199.
– volume: 77
  start-page: 219
  year: 2010
  end-page: 224
  article-title: Renal failure occurs in chronic lithium treatment but is uncommon
  publication-title: Kidney Int
– volume: 64
  start-page: 701
  year: 2004
  end-page: 723
  article-title: Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications
  publication-title: Drugs
– volume: 146
  start-page: 151
  year: 2013
  end-page: 157
  article-title: Lithium‐associated hypercalcemia and hyperparathyroidism in the elderly: what do we know?
  publication-title: J Affect Disord
– volume: 48
  start-page: 832
  year: 2006
  end-page: 837
  article-title: Normalization of lithium‐induced hypercalcemia and hyperparathyroidism with cinacalcet hydrochloride
  publication-title: Am J Kidney Dis
– volume: 32
  start-page: 2195
  year: 2008
  end-page: 2199
  article-title: Appropriate surgical treatment of lithium‐associated hyperparathyroidism
  publication-title: World J Surg
– volume: 19
  start-page: 3465
  year: 2012
  end-page: 3471
  article-title: Surgical approach and outcomes in patients with lithium‐associated hyperparathyroidism
  publication-title: Ann Surg Oncol
– year: 2014
  article-title: Treatment of manic phases of bipolar disorder: critical synthesis of international guidelines
  publication-title: Encephale
– volume: 20
  start-page: 347
  year: 2006
  end-page: 355
  article-title: Lithium: a review of its metabolic adverse effects
  publication-title: J Psychopharmacol
– volume: 152
  start-page: 1008
  year: 2012
  end-page: 1015
  article-title: Is minimally invasive parathyroidectomy associated with greater recurrence compared to bilateral exploration? Analysis of more than 1000 cases
  publication-title: Surgery
– volume: 76
  start-page: 1026
  year: 1983
  end-page: 1029
  article-title: Lithium and symptomatic hyperparathyroidism
  publication-title: J R Soc Med
– volume: 33
  start-page: 925
  year: 2011
  end-page: 927
  article-title: A profile of patients with hyperparathyroidism undergoing lithium therapy for affective psychiatric disorders
  publication-title: Head Neck
– volume: 214
  start-page: 260
  year: 2012
  end-page: 269
  article-title: Abandoning unilateral parathyroidectomy: why we reversed our position after 15 000 parathyroid operations
  publication-title: J Am Coll Surg
– volume: 45
  start-page: 62
  year: 2009
  end-page: 65
  article-title: Long‐term lithium therapy leading to hyperparathyroidism: a case report
  publication-title: Perspect Psychiatr Care
– volume: 160
  start-page: 317
  year: 2009
  end-page: 323
  article-title: Lithium‐associated hyperparathyroidism: report of four cases and review of the literature
  publication-title: Eur J Endocrinol
– volume: 110
  start-page: 1061
  year: 1991
  end-page: 1066
  article-title: Lithium effects on dispersed bovine parathyroid cells grown in tissue culture
  publication-title: Surgery
– volume: 27
  start-page: 486
  year: 2003
  end-page: 488
  article-title: Parathyroid adenomas four‐gland hyperplasia as the cause of primary hyperparathyroidism in patients with prolonged lithium therapy
  publication-title: World J Surg
– volume: 97
  start-page: 1680
  year: 2010
  end-page: 1685
  article-title: Long‐term results of surgery for lithium‐associated hyperparathyroidism
  publication-title: Br J Surg
– volume: 4
  start-page: 323
  year: 1997
  end-page: 325
  article-title: Lithium therapy, hypercalcemia, and hyperparathyroidism
  publication-title: Am J Ther
– volume: 240
  start-page: 357
  year: 1996
  end-page: 365
  article-title: Hyperparathyroidism and long‐term lithium therapy – a cross‐sectional study and the effect of lithium withdrawal
  publication-title: J Int Med
– volume: 86
  start-page: 91
  year: 1999
  end-page: 93
  article-title: Pathology and outcome of surgical treatment for lithium‐associated hyperparathyroidism
  publication-title: Br J Surg
– volume: 68
  start-page: 654
  year: 1989
  end-page: 660
  article-title: Lithium treatment increases intact and midregion parathyroid hormone and parathyroid volume
  publication-title: J Clin Endocrinol Metab
SSID ssj0013052
Score 2.2076085
Snippet Background The accepted management of lithium‐associated hyperparathyroidism (LiHPT) is open four‐gland parathyroid exploration (OPTX). This approach has...
The accepted management of lithium-associated hyperparathyroidism (LiHPT) is open four-gland parathyroid exploration (OPTX). This approach has recently been...
Background The accepted management of lithium-associated hyperparathyroidism (LiHPT) is open four-gland parathyroid exploration (OPTX). This approach has...
Background: The accepted management of lithium-associated hyperparathyroidism (LiHPT) is open four-gland parathyroid exploration (OPTX). This approach has...
SourceID swepub
proquest
pubmed
wiley
istex
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 1252
SubjectTerms Adult
Aged
Aged, 80 and over
Antidepressive Agents - adverse effects
Diagnostic Imaging - methods
Female
Humans
Hyperparathyroidism - chemically induced
Hyperparathyroidism - diagnosis
Hyperparathyroidism - surgery
Lithium Carbonate - adverse effects
Male
Middle Aged
Parathyroidectomy - methods
Preoperative Care - methods
Recurrence
Retrospective Studies
Treatment Outcome
Title Long-term outcome after parathyroidectomy for lithium-induced hyperparathyroidism
URI https://api.istex.fr/ark:/67375/WNG-LT13FL7H-C/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fbjs.9589
https://www.ncbi.nlm.nih.gov/pubmed/25043401
https://www.proquest.com/docview/1552373411
https://www.proquest.com/docview/1553106469
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-231983
Volume 101
WOSCitedRecordID wos000340606800009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library Full Collection 2020
  customDbUrl:
  eissn: 1365-2168
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0013052
  issn: 0007-1323
  databaseCode: DRFUL
  dateStart: 19980101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwEB7RLQcuBcRPA6UKEnALTew4cY6lZanQaoWgC3uz7NjuBrRJlWwQvfEIPCNPwjjJpiBxQOKUg8eJ5fnxN7bzDcAzlUvGiDFBaFMVOEY5dKk0DAyLcs1yiQFRd8Um0vmcL5fZu-FWpfsXpueHGDfcnGd08do5uFTN0TVpqPrcvMwYz3Zgl6DZsgnsnr6fLmbXZwgh67nCHQ0iJXRLPRuSo21fRKRuMr_9DV6O3KF_wtZu3Zne_p8R34G9AW36x7153IUbprwHi1lVXvz8_sMFZb9qN_ga43e1wv2OCHx1VVeFdrv56ysfMa2PSH1VtGvsggk8moL2V5i91r8JF836Piymr89PzoKhukJQUM6ywPIwUZZLG2tFlElDzPUUI1JTldmEJ4lKaIzJYiZDaiNteSKZjtJIR7HEHCmiD2BSVqXZBz_Oc-OO_Bw7fqytzIxVhioSxppoZTMPXnTTLC57Bg0h6y_uQlnKxKf5GzE7j-h0lp6JEw8OtnoQgy81wpHE0RRX28iDp2MzeoE72pClqdpOBnFqgqP14GGvv_FjHUkbppEePO8VOrY4au3T4uOxqOoL0bYCsW7GKY620-Io1jM7E4H6E05_4tXbD-756F8FH8MtxFlxfzXtACabujVP4Gb-dVM09SHspEt-OFjvL8nc9Xo
linkProvider Wiley-Blackwell
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB6VFgkuPMQrUCBIwC00ieMkFqfSsiwQVgh2oTfLju1uWm2CshtEb_wEfiO_hLGzm4LEAYlTDh4nlufhb2znG4DHshSUxloHoclkYBnl0KWyMNA0KhUtBQZE5YpNZJNJfnTE3m_B882_MD0_xLDhZj3DxWvr4HZDeu-cNVSeLJ8xmrMLsJOgFaF57xx-GM2K80OEkPZk4ZYHkcRkwz0bxnubvghJ7Wx--xu-HMhD_8StbuEZXf2vIV-DK2u86e_3BnIdtnR9A2ZFUx___P7DhmW_6Vb4Hu27auG-owKfn7VNpex-_uLMR1TrI1afV90Cu2AKj8ag_Dnmr-1vwtVycRNmo5fTg3Gwrq8QVCSnLDB5mEqTC5MoGUudhZjtSRoLRSQzaZ6mMiUJpotMhMREyuSpoCrKIhUlArOkiNyC7bqp9R3wk7LU9tDP8uMnygimjdRExmGiYiUN8-Cpm2f-pefQ4KI9tVfKMso_T17xYhqRUZGN-YEHuxtF8LU3LbmliSMZrreRB4-GZvQDe7ghat10TgaRaoqj9eB2r8DhY46mDRNJD570Gh1aLLn2YfVpnzftMe86jmiX5QRH69Q4iPXczjFH_XGrP_7izUf7vPuvgg_h0nj6ruDF68nbe3AZUVfSX1Tbhe1V2-n7cLH8uqqW7YO1Ef8CpB34gg
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3BbtQwEB2VLUJcoAgogQJBAm6hSRwnsTiVbkOBaFVBF3qz7NjuBrRJld0geuMT-o39EsbJbgoSByROOXicjDye8RvbeQPwXBaC0lBrzzeJ9CyjHLpU4nuaBoWihcCAqLpiE8lkkp6csKMNeL3-F6bnhxg23KxndPHaOrg-U2b3ijVUfl28YjRl12AzsjVkRrA5_phN86tDBJ_2ZOGWB5GEZM0964e7674ISe1o_vgbvhzIQ__Erd3Ck93-L5W34NYKb7p7_QS5Axu6ugvTvK5OL39e2LDs1u0S36Pdrlq421GBz86bulR2P39-7iKqdRGrz8p2jl0whcfJoNwZ5q_Nb8LlYn4PptnB8f6ht6qv4JUkpcwzqR9LkwoTKRlKnfiY7UkaCkUkM3EaxzImEaaLTPjEBMqksaAqSAIVRAKzpIDch1FVV_oBuFFRaHvoZ_nxI2UE00ZqIkM_UqGShjnwshtnftZzaHDRfLNXyhLKv0ze8vw4IFmeHPJ9B3bWhuArb1pwSxNHElxvAweeDc3oB_ZwQ1S6bjsZRKoxauvAdm_A4WMdTRsmkg686C06tFhy7XH5eY_XzSlvW45ol6UEte3MOIj13M4hR_txaz_-5v0n-3z4r4JP4cbROOP5u8mHR3ATQVfU31PbgdGyafVjuF58X5aL5slqDv8CPQj3_Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Long-term+outcome+after+parathyroidectomy+for+lithium-induced+hyperparathyroidism&rft.jtitle=British+journal+of+surgery&rft.au=Norl%C3%A9n%2C+O&rft.au=Sidhu%2C+S&rft.au=Sywak%2C+M&rft.au=Delbridge%2C+L&rft.date=2014-09-01&rft.eissn=1365-2168&rft.volume=101&rft.issue=10&rft.spage=1252&rft_id=info:doi/10.1002%2Fbjs.9589&rft_id=info%3Apmid%2F25043401&rft.externalDocID=25043401
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-1323&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-1323&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-1323&client=summon